Cigna Group (CI) Competitors

Cigna Group logo
$287.41 +7.95 (+2.85%)
As of 09:52 AM Eastern
This is a fair market value price provided by Massive. Learn more.

CI vs. CNC, CVS, ELV, HCA, and HUM

Should you buy Cigna Group stock or one of its competitors? MarketBeat compares Cigna Group with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Cigna Group include Centene (CNC), CVS Health (CVS), Elevance Health (ELV), HCA Healthcare (HCA), and Humana (HUM). These companies are all part of the "medical" sector.

How does Cigna Group compare to Centene?

Centene (NYSE:CNC) and Cigna Group (NYSE:CI) are both large-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, valuation, institutional ownership, risk, profitability, dividends, earnings and media sentiment.

Cigna Group has higher revenue and earnings than Centene. Centene is trading at a lower price-to-earnings ratio than Cigna Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Centene$194.78B0.17-$6.67B-$13.14N/A
Cigna Group$276.88B0.27$5.96B$23.5912.11

In the previous week, Cigna Group had 10 more articles in the media than Centene. MarketBeat recorded 21 mentions for Cigna Group and 11 mentions for Centene. Cigna Group's average media sentiment score of 1.02 beat Centene's score of 0.58 indicating that Cigna Group is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Centene
3 Very Positive mention(s)
0 Positive mention(s)
5 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Positive
Cigna Group
13 Very Positive mention(s)
1 Positive mention(s)
6 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Positive

Cigna Group has a net margin of 2.26% compared to Centene's net margin of -3.25%. Cigna Group's return on equity of 19.75% beat Centene's return on equity.

Company Net Margins Return on Equity Return on Assets
Centene-3.25% 5.57% 1.54%
Cigna Group 2.26%19.75%5.30%

93.6% of Centene shares are owned by institutional investors. Comparatively, 87.0% of Cigna Group shares are owned by institutional investors. 0.4% of Centene shares are owned by company insiders. Comparatively, 0.6% of Cigna Group shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Centene has a beta of 1.09, indicating that its share price is 9% more volatile than the broader market. Comparatively, Cigna Group has a beta of 0.28, indicating that its share price is 72% less volatile than the broader market.

Centene presently has a consensus target price of $60.78, indicating a potential downside of 6.95%. Cigna Group has a consensus target price of $338.30, indicating a potential upside of 18.38%. Given Cigna Group's stronger consensus rating and higher probable upside, analysts plainly believe Cigna Group is more favorable than Centene.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Centene
2 Sell rating(s)
10 Hold rating(s)
7 Buy rating(s)
1 Strong Buy rating(s)
2.35
Cigna Group
0 Sell rating(s)
6 Hold rating(s)
15 Buy rating(s)
1 Strong Buy rating(s)
2.77

Summary

Cigna Group beats Centene on 14 of the 16 factors compared between the two stocks.

How does Cigna Group compare to CVS Health?

CVS Health (NYSE:CVS) and Cigna Group (NYSE:CI) are both large-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their profitability, dividends, analyst recommendations, risk, institutional ownership, earnings, media sentiment and valuation.

Cigna Group has lower revenue, but higher earnings than CVS Health. Cigna Group is trading at a lower price-to-earnings ratio than CVS Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CVS Health$402.07B0.33$1.77B$2.2746.26
Cigna Group$276.88B0.27$5.96B$23.5912.11

In the previous week, CVS Health had 27 more articles in the media than Cigna Group. MarketBeat recorded 48 mentions for CVS Health and 21 mentions for Cigna Group. Cigna Group's average media sentiment score of 1.02 beat CVS Health's score of 0.82 indicating that Cigna Group is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
CVS Health
26 Very Positive mention(s)
6 Positive mention(s)
13 Neutral mention(s)
1 Negative mention(s)
1 Very Negative mention(s)
Positive
Cigna Group
13 Very Positive mention(s)
1 Positive mention(s)
6 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Positive

CVS Health has a beta of 0.62, indicating that its stock price is 38% less volatile than the broader market. Comparatively, Cigna Group has a beta of 0.28, indicating that its stock price is 72% less volatile than the broader market.

CVS Health pays an annual dividend of $2.66 per share and has a dividend yield of 2.5%. Cigna Group pays an annual dividend of $6.24 per share and has a dividend yield of 2.2%. CVS Health pays out 117.2% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Cigna Group pays out 26.5% of its earnings in the form of a dividend. CVS Health has raised its dividend for 4 consecutive years and Cigna Group has raised its dividend for 5 consecutive years.

Cigna Group has a net margin of 2.26% compared to CVS Health's net margin of 0.72%. Cigna Group's return on equity of 19.75% beat CVS Health's return on equity.

Company Net Margins Return on Equity Return on Assets
CVS Health0.72% 11.88% 3.54%
Cigna Group 2.26%19.75%5.30%

80.7% of CVS Health shares are held by institutional investors. Comparatively, 87.0% of Cigna Group shares are held by institutional investors. 0.9% of CVS Health shares are held by insiders. Comparatively, 0.6% of Cigna Group shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

CVS Health presently has a consensus price target of $101.28, suggesting a potential downside of 3.54%. Cigna Group has a consensus price target of $338.30, suggesting a potential upside of 18.38%. Given Cigna Group's higher probable upside, analysts clearly believe Cigna Group is more favorable than CVS Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
CVS Health
0 Sell rating(s)
4 Hold rating(s)
22 Buy rating(s)
0 Strong Buy rating(s)
2.85
Cigna Group
0 Sell rating(s)
6 Hold rating(s)
15 Buy rating(s)
1 Strong Buy rating(s)
2.77

Summary

Cigna Group beats CVS Health on 11 of the 20 factors compared between the two stocks.

How does Cigna Group compare to Elevance Health?

Cigna Group (NYSE:CI) and Elevance Health (NYSE:ELV) are both large-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their analyst recommendations, profitability, risk, institutional ownership, valuation, dividends, media sentiment and earnings.

87.0% of Cigna Group shares are owned by institutional investors. Comparatively, 89.2% of Elevance Health shares are owned by institutional investors. 0.6% of Cigna Group shares are owned by company insiders. Comparatively, 0.3% of Elevance Health shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Cigna Group currently has a consensus price target of $338.30, suggesting a potential upside of 18.38%. Elevance Health has a consensus price target of $416.11, suggesting a potential upside of 6.96%. Given Cigna Group's stronger consensus rating and higher probable upside, equities research analysts plainly believe Cigna Group is more favorable than Elevance Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cigna Group
0 Sell rating(s)
6 Hold rating(s)
15 Buy rating(s)
1 Strong Buy rating(s)
2.77
Elevance Health
0 Sell rating(s)
9 Hold rating(s)
14 Buy rating(s)
0 Strong Buy rating(s)
2.61

Elevance Health has a net margin of 2.62% compared to Cigna Group's net margin of 2.26%. Cigna Group's return on equity of 19.75% beat Elevance Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Cigna Group2.26% 19.75% 5.30%
Elevance Health 2.62%15.58%5.57%

Cigna Group has higher revenue and earnings than Elevance Health. Cigna Group is trading at a lower price-to-earnings ratio than Elevance Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cigna Group$276.88B0.27$5.96B$23.5912.11
Elevance Health$200.42B0.42$5.66B$23.5116.55

Cigna Group pays an annual dividend of $6.24 per share and has a dividend yield of 2.2%. Elevance Health pays an annual dividend of $6.88 per share and has a dividend yield of 1.8%. Cigna Group pays out 26.5% of its earnings in the form of a dividend. Elevance Health pays out 29.3% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Cigna Group has raised its dividend for 5 consecutive years and Elevance Health has raised its dividend for 14 consecutive years. Cigna Group is clearly the better dividend stock, given its higher yield and lower payout ratio.

In the previous week, Cigna Group had 6 more articles in the media than Elevance Health. MarketBeat recorded 21 mentions for Cigna Group and 15 mentions for Elevance Health. Elevance Health's average media sentiment score of 1.39 beat Cigna Group's score of 1.02 indicating that Elevance Health is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Cigna Group
13 Very Positive mention(s)
1 Positive mention(s)
6 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Positive
Elevance Health
11 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Cigna Group has a beta of 0.28, indicating that its share price is 72% less volatile than the broader market. Comparatively, Elevance Health has a beta of 0.67, indicating that its share price is 33% less volatile than the broader market.

Summary

Cigna Group beats Elevance Health on 12 of the 20 factors compared between the two stocks.

How does Cigna Group compare to HCA Healthcare?

HCA Healthcare (NYSE:HCA) and Cigna Group (NYSE:CI) are both large-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, valuation, media sentiment, analyst recommendations, profitability, earnings, dividends and institutional ownership.

HCA Healthcare has a net margin of 8.89% compared to Cigna Group's net margin of 2.26%. Cigna Group's return on equity of 19.75% beat HCA Healthcare's return on equity.

Company Net Margins Return on Equity Return on Assets
HCA Healthcare8.89% -295.93% 11.21%
Cigna Group 2.26%19.75%5.30%

HCA Healthcare currently has a consensus target price of $503.00, indicating a potential upside of 28.12%. Cigna Group has a consensus target price of $338.30, indicating a potential upside of 18.38%. Given HCA Healthcare's higher probable upside, analysts clearly believe HCA Healthcare is more favorable than Cigna Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
HCA Healthcare
1 Sell rating(s)
8 Hold rating(s)
15 Buy rating(s)
0 Strong Buy rating(s)
2.58
Cigna Group
0 Sell rating(s)
6 Hold rating(s)
15 Buy rating(s)
1 Strong Buy rating(s)
2.77

62.7% of HCA Healthcare shares are owned by institutional investors. Comparatively, 87.0% of Cigna Group shares are owned by institutional investors. 1.5% of HCA Healthcare shares are owned by insiders. Comparatively, 0.6% of Cigna Group shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

HCA Healthcare pays an annual dividend of $3.12 per share and has a dividend yield of 0.8%. Cigna Group pays an annual dividend of $6.24 per share and has a dividend yield of 2.2%. HCA Healthcare pays out 10.7% of its earnings in the form of a dividend. Cigna Group pays out 26.5% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. HCA Healthcare has increased its dividend for 6 consecutive years and Cigna Group has increased its dividend for 5 consecutive years.

HCA Healthcare has a beta of 1.12, meaning that its share price is 12% more volatile than the broader market. Comparatively, Cigna Group has a beta of 0.28, meaning that its share price is 72% less volatile than the broader market.

HCA Healthcare has higher earnings, but lower revenue than Cigna Group. Cigna Group is trading at a lower price-to-earnings ratio than HCA Healthcare, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
HCA Healthcare$75.60B1.15$6.78B$29.0813.50
Cigna Group$276.88B0.27$5.96B$23.5912.11

In the previous week, Cigna Group had 8 more articles in the media than HCA Healthcare. MarketBeat recorded 21 mentions for Cigna Group and 13 mentions for HCA Healthcare. Cigna Group's average media sentiment score of 1.02 beat HCA Healthcare's score of 0.60 indicating that Cigna Group is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
HCA Healthcare
7 Very Positive mention(s)
2 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Cigna Group
13 Very Positive mention(s)
1 Positive mention(s)
6 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Positive

Summary

HCA Healthcare beats Cigna Group on 11 of the 19 factors compared between the two stocks.

How does Cigna Group compare to Humana?

Humana (NYSE:HUM) and Cigna Group (NYSE:CI) are both large-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, dividends, profitability, analyst recommendations, valuation, risk, institutional ownership and media sentiment.

Humana currently has a consensus price target of $293.09, indicating a potential downside of 22.58%. Cigna Group has a consensus price target of $338.30, indicating a potential upside of 18.38%. Given Cigna Group's stronger consensus rating and higher possible upside, analysts plainly believe Cigna Group is more favorable than Humana.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Humana
3 Sell rating(s)
16 Hold rating(s)
8 Buy rating(s)
1 Strong Buy rating(s)
2.25
Cigna Group
0 Sell rating(s)
6 Hold rating(s)
15 Buy rating(s)
1 Strong Buy rating(s)
2.77

In the previous week, Cigna Group had 11 more articles in the media than Humana. MarketBeat recorded 21 mentions for Cigna Group and 10 mentions for Humana. Cigna Group's average media sentiment score of 1.02 beat Humana's score of 0.52 indicating that Cigna Group is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Humana
3 Very Positive mention(s)
1 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Positive
Cigna Group
13 Very Positive mention(s)
1 Positive mention(s)
6 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Positive

Humana has a beta of 0.76, meaning that its share price is 24% less volatile than the broader market. Comparatively, Cigna Group has a beta of 0.28, meaning that its share price is 72% less volatile than the broader market.

Cigna Group has higher revenue and earnings than Humana. Cigna Group is trading at a lower price-to-earnings ratio than Humana, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Humana$137.20B0.33$1.19B$9.3540.49
Cigna Group$276.88B0.27$5.96B$23.5912.11

Humana pays an annual dividend of $3.54 per share and has a dividend yield of 0.9%. Cigna Group pays an annual dividend of $6.24 per share and has a dividend yield of 2.2%. Humana pays out 37.9% of its earnings in the form of a dividend. Cigna Group pays out 26.5% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Cigna Group has raised its dividend for 5 consecutive years. Cigna Group is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Cigna Group has a net margin of 2.26% compared to Humana's net margin of 0.82%. Cigna Group's return on equity of 19.75% beat Humana's return on equity.

Company Net Margins Return on Equity Return on Assets
Humana0.82% 10.45% 3.75%
Cigna Group 2.26%19.75%5.30%

92.4% of Humana shares are owned by institutional investors. Comparatively, 87.0% of Cigna Group shares are owned by institutional investors. 0.2% of Humana shares are owned by insiders. Comparatively, 0.6% of Cigna Group shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Summary

Cigna Group beats Humana on 15 of the 19 factors compared between the two stocks.

Get Cigna Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for CI and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CI vs. The Competition

MetricCigna GroupMED IndustryMedical SectorNYSE Exchange
Market Cap$75.42B$53.14B$6.61B$23.16B
Dividend Yield2.20%1.75%2.68%4.06%
P/E Ratio12.0925.4025.7631.50
Price / Sales0.270.65550.1920.76
Price / Cash6.8324.5346.3324.53
Price / Book1.802.8710.574.69
Net Income$5.96B$1.46B$3.57B$1.07B
7 Day Performance2.20%-3.31%0.76%-0.15%
1 Month Performance1.62%0.71%0.19%-0.18%
1 Year Performance-13.05%-3.45%30.79%23.79%

Cigna Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CI
Cigna Group
4.7784 of 5 stars
$285.79
+1.4%
$338.30
+18.4%
-10.6%$75.42B$276.88B12.0967,700
CNC
Centene
3.1689 of 5 stars
$63.56
-2.5%
$60.24
-5.2%
+20.8%$31.39B$194.78BN/A61,100
CVS
CVS Health
3.4257 of 5 stars
$100.55
-1.4%
$100.68
+0.1%
+57.3%$128.30B$407.91B44.30300,000
ELV
Elevance Health
4.8555 of 5 stars
$405.15
+0.3%
$416.11
+2.7%
+3.4%$87.98B$199.13B17.2397,100
HCA
HCA Healthcare
4.7222 of 5 stars
$390.08
+0.7%
$506.14
+29.8%
+3.6%$86.54B$75.60B13.41320,000

Related Companies and Tools


This page (NYSE:CI) was last updated on 6/26/2026 by MarketBeat.com Staff.
From Our Partners